At the recent Abuse deterrent opioids summit, CDER Deputy Director for Regulatory Programs Dr. Doug Throckmorton presented the FDA’s position. He said, “We must move on from older to newer technologies. Amen. But how?
This post first appeared on Drugwonks | Welcome To The New Drugwonks.com, please read the originial post: here
